COMPREHENSIVE BOARD EXAMINATION IN CLINICAL
PSYCHOPHARMACOLOGY & NEUROANATOMY
200 Rigorous Multiple-Choice Questions with Detailed Clinical
Rationales
Focus: Late-Onset Schizophrenia, Basal Ganglia Circuitry,
Dopaminergic Pathways, EPS, and Geriatric Psychopharmacotherapy
Question 1: A 65-year-old male with late-onset schizophrenia is
admitted to the inpatient psychiatric unit and started on high-potency
haloperidol. Within 36 hours, he develops acute oculogyric crises,
torticollis, and severe facial grimacing. Which anatomical pathway and
neurotransmitter receptor blockade are primarily responsible for this
extrapyramidal symptom?
A) Mesolimbic pathway; dopamine D2 receptor blockade
B) Nigrostriatal pathway; dopamine D2 receptor blockade
C) Tuberoinfundibular pathway; dopamine D2 receptor blockade
D) Mesocortical pathway; serotonin 5-HT2A receptor blockade
Correct Answer: (B) | Rationale: Acute dystonic reactions are
hallmark EPS caused by acute antagonism of dopamine D2
receptors within the nigrostriatal pathway (substantia nigra pars
compacta to dorsal striatum). In older adults, reduced baseline
dopaminergic reserve heightens vulnerability. Blocking striatal D2
receptors disrupts dopamine-acetylcholine balance, causing
unopposed cholinergic hyperactivity that drives involuntary muscle
spasms.
Question 2: Following the acute dystonic reaction to haloperidol in this
65-year-old patient, the treatment team decides to administer an
Advanced Clinical Psychopharmacology & Neuroanatomy Board Exam — 200 Questions
,anticholinergic medication for rapid symptom reversal. Which specific
drug and mechanism of action are most appropriate?
A) Donepezil; acetylcholinesterase inhibition
B) Benztropine; central muscarinic acetylcholine receptor
antagonism
C) Baclofen; GABA-B receptor agonism
D) Dantrolene; ryanodine receptor antagonism
Correct Answer: (B) | Rationale: Benztropine is a centrally acting
anticholinergic (antimuscarinic) agent that restores the striatal
dopamine-acetylcholine balance by blocking muscarinic receptors,
rapidly reversing acute dystonia.
Question 3: Late-onset schizophrenia, as diagnosed in this 65-year-old
male, typically presents after which age threshold, and how does its
clinical phenotype characteristically differ from early-onset
schizophrenia?
A) Age 25; characterized by severe cognitive decline and prominent
negative symptoms
B) Age 40; characterized by higher prevalence of
paranoid/persecutory delusions and preserved cognitive function
relative to early-onset
C) Age 60; characterized exclusively by tactile hallucinations and
formication
D) Age 50; characterized by complete absence of auditory
hallucinations and prominent ataxia
Correct Answer: (B) | Rationale: Late-onset schizophrenia is
defined by onset after age 40 (often divided into late-onset at 40-60
and very-late-onset after 60). It classically features prominent
Advanced Clinical Psychopharmacology & Neuroanatomy Board Exam — 200 Questions
, persecutory delusions, visual or auditory hallucinations, and
relatively preserved cognitive functioning compared to early-onset
disease.
Question 4: Haloperidol is classified as a high-potency first-generation
antipsychotic (FGA). What is its primary binding characteristic at the
dopamine D2 receptor that accounts for its high propensity to cause
extrapyramidal symptoms compared to second-generation antipsychotic
agents?
A) Rapid dissociation rate from the D2 receptor
B) Tight, slow, and high-affinity binding blockade of the D2
receptor
C) Selective partial agonism at presynaptic autoreceptors
D) Irreversible covalent modification of the D2 receptor protein
Correct Answer: (B) | Rationale: High-potency FGAs like
haloperidol exhibit high affinity and slow dissociation rates from
striatal D2 receptors. Sustained blockade (>80% occupancy)
triggers EPS, whereas atypical antipsychotics have faster off-rates
or serotonin-dopamine antagonism.
Advanced Clinical Psychopharmacology & Neuroanatomy Board Exam — 200 Questions
, Question 5: In the basal ganglia direct pathway, striatal medium spiny
neurons project directly to which output nucleus, and what is their
primary inhibitory neurotransmitter?
A) Subthalamic nucleus; glutamate
B) Globus pallidus internus / Substantia nigra pars reticulata;
GABA
C) Thalamus; acetylcholine
D) Globus pallidus externus; dopamine
Correct Answer: (B) | Rationale: The direct pathway consists of
striatal D1-expressing medium spiny neurons projecting directly to
the internal globus pallidus (GPi) and substantia nigra pars
reticulata (SNr) using GABA and substance P, facilitating
movement.
Question 6: Conversely, in the basal ganglia indirect pathway, striatal
medium spiny neurons expressing D2 receptors project first to which
structure?
A) Globus pallidus externus (GPe)
B) Substantia nigra pars compacta (SNc)
C) Ventral tegmental area (VTA)
D) Pedunculopontine nucleus
Correct Answer: (A) | Rationale: The indirect pathway starts with
striatal D2-expressing medium spiny neurons projecting to the
external globus pallidus (GPe), modulating subthalamic and
pallidal outflow to inhibit movement.
Advanced Clinical Psychopharmacology & Neuroanatomy Board Exam — 200 Questions
PSYCHOPHARMACOLOGY & NEUROANATOMY
200 Rigorous Multiple-Choice Questions with Detailed Clinical
Rationales
Focus: Late-Onset Schizophrenia, Basal Ganglia Circuitry,
Dopaminergic Pathways, EPS, and Geriatric Psychopharmacotherapy
Question 1: A 65-year-old male with late-onset schizophrenia is
admitted to the inpatient psychiatric unit and started on high-potency
haloperidol. Within 36 hours, he develops acute oculogyric crises,
torticollis, and severe facial grimacing. Which anatomical pathway and
neurotransmitter receptor blockade are primarily responsible for this
extrapyramidal symptom?
A) Mesolimbic pathway; dopamine D2 receptor blockade
B) Nigrostriatal pathway; dopamine D2 receptor blockade
C) Tuberoinfundibular pathway; dopamine D2 receptor blockade
D) Mesocortical pathway; serotonin 5-HT2A receptor blockade
Correct Answer: (B) | Rationale: Acute dystonic reactions are
hallmark EPS caused by acute antagonism of dopamine D2
receptors within the nigrostriatal pathway (substantia nigra pars
compacta to dorsal striatum). In older adults, reduced baseline
dopaminergic reserve heightens vulnerability. Blocking striatal D2
receptors disrupts dopamine-acetylcholine balance, causing
unopposed cholinergic hyperactivity that drives involuntary muscle
spasms.
Question 2: Following the acute dystonic reaction to haloperidol in this
65-year-old patient, the treatment team decides to administer an
Advanced Clinical Psychopharmacology & Neuroanatomy Board Exam — 200 Questions
,anticholinergic medication for rapid symptom reversal. Which specific
drug and mechanism of action are most appropriate?
A) Donepezil; acetylcholinesterase inhibition
B) Benztropine; central muscarinic acetylcholine receptor
antagonism
C) Baclofen; GABA-B receptor agonism
D) Dantrolene; ryanodine receptor antagonism
Correct Answer: (B) | Rationale: Benztropine is a centrally acting
anticholinergic (antimuscarinic) agent that restores the striatal
dopamine-acetylcholine balance by blocking muscarinic receptors,
rapidly reversing acute dystonia.
Question 3: Late-onset schizophrenia, as diagnosed in this 65-year-old
male, typically presents after which age threshold, and how does its
clinical phenotype characteristically differ from early-onset
schizophrenia?
A) Age 25; characterized by severe cognitive decline and prominent
negative symptoms
B) Age 40; characterized by higher prevalence of
paranoid/persecutory delusions and preserved cognitive function
relative to early-onset
C) Age 60; characterized exclusively by tactile hallucinations and
formication
D) Age 50; characterized by complete absence of auditory
hallucinations and prominent ataxia
Correct Answer: (B) | Rationale: Late-onset schizophrenia is
defined by onset after age 40 (often divided into late-onset at 40-60
and very-late-onset after 60). It classically features prominent
Advanced Clinical Psychopharmacology & Neuroanatomy Board Exam — 200 Questions
, persecutory delusions, visual or auditory hallucinations, and
relatively preserved cognitive functioning compared to early-onset
disease.
Question 4: Haloperidol is classified as a high-potency first-generation
antipsychotic (FGA). What is its primary binding characteristic at the
dopamine D2 receptor that accounts for its high propensity to cause
extrapyramidal symptoms compared to second-generation antipsychotic
agents?
A) Rapid dissociation rate from the D2 receptor
B) Tight, slow, and high-affinity binding blockade of the D2
receptor
C) Selective partial agonism at presynaptic autoreceptors
D) Irreversible covalent modification of the D2 receptor protein
Correct Answer: (B) | Rationale: High-potency FGAs like
haloperidol exhibit high affinity and slow dissociation rates from
striatal D2 receptors. Sustained blockade (>80% occupancy)
triggers EPS, whereas atypical antipsychotics have faster off-rates
or serotonin-dopamine antagonism.
Advanced Clinical Psychopharmacology & Neuroanatomy Board Exam — 200 Questions
, Question 5: In the basal ganglia direct pathway, striatal medium spiny
neurons project directly to which output nucleus, and what is their
primary inhibitory neurotransmitter?
A) Subthalamic nucleus; glutamate
B) Globus pallidus internus / Substantia nigra pars reticulata;
GABA
C) Thalamus; acetylcholine
D) Globus pallidus externus; dopamine
Correct Answer: (B) | Rationale: The direct pathway consists of
striatal D1-expressing medium spiny neurons projecting directly to
the internal globus pallidus (GPi) and substantia nigra pars
reticulata (SNr) using GABA and substance P, facilitating
movement.
Question 6: Conversely, in the basal ganglia indirect pathway, striatal
medium spiny neurons expressing D2 receptors project first to which
structure?
A) Globus pallidus externus (GPe)
B) Substantia nigra pars compacta (SNc)
C) Ventral tegmental area (VTA)
D) Pedunculopontine nucleus
Correct Answer: (A) | Rationale: The indirect pathway starts with
striatal D2-expressing medium spiny neurons projecting to the
external globus pallidus (GPe), modulating subthalamic and
pallidal outflow to inhibit movement.
Advanced Clinical Psychopharmacology & Neuroanatomy Board Exam — 200 Questions
